Geratherm Medical AG (XTER:GME) Cash-to-Debt : 1.34 (As of Jun. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Geratherm Medical AG Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Geratherm Medical AG's cash to debt ratio for the quarter that ended in Jun. 2023 was 1.34.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Geratherm Medical AG could pay off its debt using the cash in hand for the quarter that ended in Jun. 2023.

The historical rank and industry rank for Geratherm Medical AG's Cash-to-Debt or its related term are showing as below:

XTER:GME' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.57 Med: 2.65 Max: 5.4
Current: 1.34

During the past 13 years, Geratherm Medical AG's highest Cash to Debt Ratio was 5.40. The lowest was 0.57. And the median was 2.65.

XTER:GME's Cash-to-Debt is ranked worse than
55.9% of 864 companies
in the Medical Devices & Instruments industry
Industry Median: 1.84 vs XTER:GME: 1.34

Geratherm Medical AG Cash-to-Debt Historical Data

The historical data trend for Geratherm Medical AG's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Geratherm Medical AG Cash-to-Debt Chart

Geratherm Medical AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash-to-Debt

Get a 7-Day Free Trial

2.21

1.23

0.99

0.57

1.17

Geratherm Medical AG Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23
Cash-to-Debt	Get a 7-Day Free Trial															0.63	1.16	1.00	1.17	1.34

Competitive Comparison of Geratherm Medical AG's Cash-to-Debt

For the Medical Devices subindustry, Geratherm Medical AG's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Geratherm Medical AG's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Geratherm Medical AG's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Geratherm Medical AG's Cash-to-Debt falls into.

Geratherm Medical AG Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Geratherm Medical AG's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	10.886	/	(0	+	9.295)
	=	1.17

Geratherm Medical AG's Cash to Debt Ratio for the quarter that ended in Jun. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	10.896	/	(0	+	8.15)
	=	1.34

Geratherm Medical AG (XTER:GME) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Geratherm Medical AG Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Geratherm Medical AG's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Geratherm Medical AG (XTER:GME) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Geratherm Medical AG (XTER:GME) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

GME:Germany

Address

Fahrenheitstrasse 1, Geratal, DEU, 99331

Website

https://www.geratherm.com

Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.

Executives